Intensive Motor Rehabilitation With Technology for Patients With Central Neurological Disease (INTeRAcT)


Catholic University (KU) of Leuven

Status and phase

Phase 3
Phase 2


Chronic Disease
Spinal Cord Injuries


Other: Intensive rehabilitation programme

Study type


Funder types




Details and patient eligibility


This project will consist of 1 large clinical trial with 2 core concepts: (1) Clinical benefits of an intensive rehabilitation programme using advanced technology, compared to the control group; (2) A full health economic evaluation combined with model-based estimation of costs and benefits.


100 estimated patients




18+ years old


No Healthy Volunteers

Inclusion criteria

Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures;

A diagnosis of central neurological disease, made by a specialist. Conditions may include stroke or spinal cord injury:

  • Stroke: Participants must have received a diagnosis of stroke for the first time, have been diagnosed at least 3 months ago, and live at home.
  • SCI: Participants have a rating A, B, C or D on the American Spinal Injury Association (ASIA) measurement scale, which refers to patients with complete or incomplete impairment. All levels of SCI can be included, if there is a clear patient need linked to the upper and/or lower extremities.
  • At least 3 months post discharge from hospital/rehabilitation centre, living at home;
  • Having a maximum recovery of 85% of independence in daily functioning (FIM/SCIM);
  • Had a normal functional state prior to the pathology: a pre-pathology Barthel Index > 85/100;
  • Unilateral or bilateral weakness of the affected upper or lower limbs (No maximum score in all affected limbs = motricity index: score 5 on 3/3 segments)
  • Having the clinical opportunity to engage in exercise therapy with available technology, assessed by a specialist;
  • Age of > 18 years;
  • Sufficient cognitive ability to understand the games and give informed consent, assessed by a specialist;.

Exclusion criteria

  • Having other neurological or musculoskeletal conditions that may affect the protocol, assessed by a specialist;
  • No ability to initiate movements against gravity in the upper and lower limbs;
  • Severe visual impairment, communication, cognitive and language formation problems that would prevent the intervention and measurement process, assessed by a specialist;
  • Any disorder, which in the investigator's opinion might the compromise participant's safety or compliance with the CIP;
  • Female who is pregnant, breast-feeding.

Trial design

100 participants in 2 patient groups

Intensive rehabilitation program
Experimental group
3 weeks of intensive rehabilitation --> follow-up 9 months standard care
Other: Intensive rehabilitation programme
Standard care
No Intervention group
Follow-up 9 months standard care --> 3 weeks of intensive rehabilitation

Trial contacts and locations



Data sourced from

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems